Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286221 · ClinicalTrials.gov registry record · Phase 2
IVPCA in the Management of Pain Following Major Intracranial Surgery
A Phase 2 study of Intracranial Surgery, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 159
- Enrollment target
- 1
- Study location
NCT00286221 is a Phase 2 study of Intracranial Surgery that has completed, run by Johns Hopkins University. The registered enrollment target is 159 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00286221, a Phase 2 study of Intracranial Surgery, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 159 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized controlled clinical trial to evaluate the efficacy and safety of intravenous patient controlled analgesia (IVPCA) in patients following major intracranial surgery (e.g. brain tumors, vascular surgery). We will compare pain, opioid consumption, costs, sedation level, length of hospital stay, patient satisfaction, and complications in patients randomized to receive either pro re nata (PRN) or IVPCA opioids. We hypothesize that IVPCA will be more efficacious than PRN opioids in the treatment of postoperative without an increased incidence of adverse effects.
Conditions Studied
Interventions
- DRUG PCA fentanyl
- DRUG PRN fentanyl
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2006-03 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00286221
The ClinicalTrials.gov registry entry for NCT00286221 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intracranial Surgery appearing as the primary indexed condition, and to 2 interventions - of which PCA fentanyl is the first listed.
NCT00286221 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00286221 about?
NCT00286221 is a clinical study titled "IVPCA in the Management of Pain Following Major Intracranial Surgery". This is a prospective, randomized controlled clinical trial to evaluate the efficacy and safety of intravenous patient controlled analgesia (IVPCA) in patients following major intracranial surgery (e.g. brain tumors, vascular surgery). We will compare pain, opioid consumption, costs, sedation level,...
What is the current status of trial NCT00286221?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 159 participants. The study started on 2006-03. Estimated completion is 2010-07.
What conditions does trial NCT00286221 study?
This clinical trial studies the following conditions: Intracranial Surgery.
What interventions are being tested in trial NCT00286221?
The interventions under investigation include: PCA fentanyl (DRUG), PRN fentanyl (DRUG).
Who is sponsoring clinical trial NCT00286221?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00286221 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.